Syx, Delfien
Tran, Phuong B.
Miller, Rachel E.
Malfait, Anne-Marie
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR070328)., R01AR064251 and R01AR060364)
Article History
First Online: 26 February 2018
Compliance with Ethical Standards
:
: Dr. Malfait reports personal fees from Regeneron, personal fees from Eli Lilly, personal fees from Pfizer, personal fees from Galapagos, outside the submitted work.Delfien Syx, Phuong B. Tran and Rachel E. Miller declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.